A cytostatic drug improves control of HIV-1 replication during structured treatment interruptionsFelipe García, José M. Gatell, Montserrat Plana et al.|AIDS|2003Cited by 51
Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS)Consuelo Viladés, Lander Egaña-Gorrondo, Xavier Escoté et al.|Journal of Antimicrobial Chemotherapy|2014Cited by 22
Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell countMaría J. Ruiz-de-León, Joaquim Peraire, Alfonso Cabello et al.|Journal of Microbiology Immunology and Infection|2018Cited by 20
HIV/antiretroviral therapy–related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasmaJoaquim Peraire, Francesc Vidal, Miguel López-Dupla et al.|Clinical Microbiology and Infection|2015Cited by 12
Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapyFrancesc Vidal, Josep M. Gatell, Peré Domingo et al.|Expert Opinion on Drug Metabolism & Toxicology|2011Cited by 9